Bridging equity gaps through vision care
New study incorporates diversity, equity and inclusion into a clinical trial for age-related macular degeneration, aiming to restore vision and rebuild trust in marginalized communities.
Stay updated with breaking news from Regenerative Patch Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New study incorporates diversity, equity and inclusion into a clinical trial for age-related macular degeneration, aiming to restore vision and rebuild trust in marginalized communities.
/PRNewswire/ -- DelveInsight's Stargardt Disease Market Insights report includes a comprehensive understanding of current treatment practices, Stargardt...
/PRNewswire/ -- DelveInsight's Dry Age-related Macular Degeneration Market Insights report includes a comprehensive understanding of current treatment...
A stem cell patch developed by USC researchers for patients with macular degeneration will soon be tested in a phase 2b clinical trial.
/PRNewswire/ -- DelveInsight's Geographic Atrophy Market Insights report includes a comprehensive understanding of current treatment practices, geographic...